Faeth Therapeutics, Inc. Increase (Decrease) in Other Operating Liabilities
Faeth Therapeutics, Inc. (FTH) reported Increase (Decrease) in Other Operating Liabilities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-03-30
- Faeth Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $0.00.
- Faeth Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Faeth Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2024-12-31 was $0.00.
- Faeth Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2024-03-31 was $1.00K, a 97.22% decline year-over-year.
- Faeth Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was $0.00.
- Faeth Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2024 was -$67.00K, a 203.08% decline from fiscal 2023.
- Faeth Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was $65.00K.
- Faeth Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was -$16.00K, a 107.80% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | ||||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | |||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$67.00K 10-K · filed 2026-03-30 | |||||
| 2024-09-30 | -$67.00K 10-Q · filed 2025-11-14 | ||||||
| 2024-03-31 | $1.00K 10-Q · filed 2025-05-06 | $1.00K derived: sum of 2 quarters · filed 2025-05-06 | -$8.00K derived: sum of 3 quarters · filed 2025-05-06 | $30.00K derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$9.00K derived: sum of 2 quarters · filed 2025-03-28 | $29.00K derived: sum of 3 quarters · filed 2025-03-28 | $65.00K 10-K · filed 2025-03-28 | |||
| 2023-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $29.00K derived: sum of 2 quarters · filed 2024-11-14 | $65.00K 10-Q · filed 2024-11-14 | $64.00K derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $74.00K 10-Q · filed 2024-08-06 | $73.00K derived: sum of 3 quarters · filed 2024-08-06 | $74.00K derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $36.00K 10-Q · filed 2024-05-09 | $35.00K derived: sum of 2 quarters · filed 2024-05-09 | $36.00K derived: sum of 3 quarters · filed 2024-05-09 | $35.00K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | -$1.00K derived: sum of 3 quarters · filed 2024-02-29 | -$16.00K 10-K · filed 2024-02-29 | |||
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | -$15.00K 10-Q · filed 2023-11-07 | $391.00K derived: sum of 4 quarters · filed 2023-11-07 | |||
| 2022-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$16.00K 10-Q · filed 2023-08-03 | $390.00K derived: sum of 3 quarters · filed 2023-08-03 | $131.00K derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | -$15.00K 10-Q · filed 2023-05-09 | $391.00K derived: sum of 2 quarters · filed 2023-05-09 | $132.00K derived: sum of 3 quarters · filed 2023-05-09 | $138.00K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $147.00K derived: sum of 2 quarters · filed 2023-03-29 | $153.00K derived: sum of 3 quarters · filed 2023-03-29 | $205.00K 10-K · filed 2023-03-29 | |||
| 2021-09-30 | -$259.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$253.00K derived: sum of 2 quarters · filed 2022-11-08 | -$201.00K 10-Q · filed 2022-11-08 | $498.00K 10-Q · filed 2021-11-10 | $7.00K derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $58.00K 10-Q · filed 2022-08-09 | $238.00K 10-Q · filed 2021-08-11 | $266.00K derived: sum of 3 quarters · filed 2022-08-09 | $681.00K derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-03-31 | $52.00K 10-Q · filed 2022-05-10 | -$423.00K 10-Q · filed 2021-05-13 | $260.00K derived: sum of 2 quarters · filed 2022-05-10 | $675.00K derived: sum of 3 quarters · filed 2022-05-10 | $903.00K derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $623.00K derived: sum of 2 quarters · filed 2022-03-15 | $851.00K derived: sum of 3 quarters · filed 2022-03-15 | $249.00K 10-K · filed 2022-03-15 | |||
| 2020-09-30 | $415.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $643.00K derived: sum of 2 quarters · filed 2021-11-10 | $41.00K 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$374.00K 10-Q · filed 2021-08-11 | |||||
| 2020-03-31 | -$602.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |